LABIANA HEALTH S.A.EO-10 Total Assets
LABIANA HEALTH S.A.EO-10 total assets. Based on the latest financial reports, LABIANA HEALTH S.A.EO-10 (8RK) holds total assets worth €57.54 Million EUR (≈ $67.27 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see LABIANA HEALTH S.A.EO-10 market cap and net worth for the company's overall valuation and market capitalisation.
Total Assets of LABIANA HEALTH S.A.EO-10 (2021–2025)
Total assets of LABIANA HEALTH S.A.EO-10 from 2021 to 2025. This chart illustrates how LABIANA HEALTH S.A.EO-10's total assets have evolved over time, based on quarterly financial data. See 8RK live share price for real-time trading data and today's change.
LABIANA HEALTH S.A.EO-10 - Asset Composition Analysis
LABIANA HEALTH S.A.EO-10 Total Assets Breakdown (December 2025)
LABIANA HEALTH S.A.EO-10 total assets breakdown as of December 2025. LABIANA HEALTH S.A.EO-10's total assets of €57.54 Million consist of 54.8% current assets and 45.2% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 10.3% |
| Accounts Receivable | €10.39 Million | 18.1% |
| Inventory | €12.03 Million | 20.9% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €6.19 Million | 10.8% |
| Goodwill | €-0.01 | 0.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how LABIANA HEALTH S.A.EO-10's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore LABIANA HEALTH S.A.EO-10 working capital to net assets to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: LABIANA HEALTH S.A.EO-10's current assets represent 54.8% of total assets in 2025, an increase from 43.0% in 2021.
- Cash Position: Cash and equivalents constituted 10.3% of total assets in 2025, up from 4.8% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, a decrease from 17.0% in 2021.
- Asset Diversification: The largest asset category is inventory at 20.9% of total assets.
LABIANA HEALTH S.A.EO-10 Competitors by Total Assets
Key competitors of LABIANA HEALTH S.A.EO-10 based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Viatris Inc
NASDAQ:VTRS
|
USA | $35.04 Billion |
|
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
SHG:600329
|
China | CN¥11.59 Billion |
|
Walvax BioTech
SHE:300142
|
China | CN¥10.50 Billion |
|
Curaleaf Holdings Inc.
TO:CURA
|
Canada | CA$2.88 Billion |
|
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026
|
China | CN¥10.37 Billion |
|
Changzhou Qianhong Biopharma Co Ltd
SHE:002550
|
China | CN¥3.23 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Harbin Gloria Pharmaceuticals
SHE:002437
|
China | CN¥3.14 Billion |
LABIANA HEALTH S.A.EO-10 - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.39 | 1.30 | 1.32 |
| Quick Ratio | 0.86 | 0.84 | 0.80 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €8.87 Million | €6.54 Million | €6.89 Million |
LABIANA HEALTH S.A.EO-10 - Advanced Valuation Insights
This section examines the relationship between LABIANA HEALTH S.A.EO-10's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 10.10 |
| Latest Market Cap to Assets Ratio | 0.85 |
| Asset Growth Rate (YoY) | 10.7% |
| Total Assets | €57.54 Million |
| Market Capitalization | $48.63 Million USD |
Valuation Analysis
Near Book Valuation: The market values LABIANA HEALTH S.A.EO-10's assets close to their book value (0.85x), suggesting investors view the company's assets at approximately fair value.
Rapid Asset Growth: LABIANA HEALTH S.A.EO-10's assets grew by 10.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for LABIANA HEALTH S.A.EO-10 (2021–2025)
The table below shows the annual total assets of LABIANA HEALTH S.A.EO-10 from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €57.54 Million ≈ $67.27 Million |
+10.66% |
| 2024-12-31 | €52.00 Million ≈ $60.80 Million |
-12.05% |
| 2023-12-31 | €59.12 Million ≈ $69.12 Million |
-2.72% |
| 2022-12-31 | €60.78 Million ≈ $71.06 Million |
-11.10% |
| 2021-12-31 | €68.37 Million ≈ $79.93 Million |
-- |
About LABIANA HEALTH S.A.EO-10
Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, North America, and internationally. It offers anesthetics-sedatives, anti-infectives, anti-inflammatories, antiparasitics, hormonals, nutritional products, metabolism regulators, and vitamin products. The company also provides sterile and lyophilized dosage f… Read more